DUBLIN--(BUSINESS WIRE)--The "Blood Transfusion Devices Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.
Certain factors driving market growth are an increasing number of surgical procedures, increasing accidents and trauma cases, the rise in a number of blood disorders, and technological development.
The most commonly performed surgeries that require blood transfusion include cardiovascular procedures, C-section procedures, and trauma and accident injuries. As per estimates by the NIH, and National Heart, Lung, and Blood Institute, blood transfusions are very common in the United States, as each year, over 5 million Americans need blood transfusions. A majority of the surgeries performed are for cardiovascular interventions. Also, due to natural calamities and widespread causalities, the demand for blood transfusion is increasing across the globe.
The rise in the number of blood disorders, such as anemia, leukopenia, erythrocytosis, leukocytosis, and thrombocytosis is also boosting the blood transfusion market. As per the WHO, most children with thalassemia are born in low-income countries, where access to blood transfusion is difficult or is available to only a small percentage of the population.
The pathogen reduction system segment of the blood transfusion market is believed to witness a healthy growrh over the forecast period. The demand for pathogen reduction system is growing with the emergence of a cost-effective and innovative solution to inactivate or reduce the risk of infection. For example, the INTERCEPT Blood System from Cerus Corporation has significantly enhanced blood safety at more than 100 blood centers, worldwide.
North America currently dominates the market for blood transfusion devices and is expected to remain strong in the future due to an increasing number of trauma cases and surgical procedures, which are driving the demand for blood transfusion. The United States holds the majority of the market in North America. As per the estimates of the American National Red Cross, approximately 36,000 units of red blood cells are needed every day, and nearly 21 million blood components are transfused each year in the United States. This indicates the high demand for blood transfusion in the country. These statistics also indicate the high requirement for blood transfusion products. Thus, ensuring a consistent supply of these products is crucial to support the growing healthcare requirements in the region.
The blood transfusion market is moderately competitive and consists of several major players. However, with technological advancements and product innovation, mid-size to smaller companies are increasing their market presence by introducing new products with cost-effective pricing. Companies like Immucor Inc., Becton Dickinson, B. Braun, Terumo Corporation, and Grifols SA., hold a significant share in the blood transfusion market.
Key Topics Covered:
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Number of Surgical Procedures
4.2.2 Rise in the Number of Blood Disorders
4.2.3 Technological Advancements in the Devices
4.3 Market Restraints
4.3.1 Stringent Regulatory Framework
4.3.2 High Costs Associated with Handling of Blood and its Components
4.4 Industry Attractiveness - Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Blood Bag and Accessory
5.1.2 Blood Mixer
5.1.4 Blood Component Separator
5.1.5 Apheresis Device
5.1.6 Pathogen Reduction System
5.1.7 Consumables and Supplies
5.1.8 Other Products
5.2 By End-user
5.2.2 Ambulatory Surgical Centres
5.2.3 Blood Bank
5.2.4 Other End-users
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Immucor Inc.
6.1.2 Becton Dickinson
6.1.3 B. Braun Melsungen AG
6.1.4 Terumo Corporation
6.1.5 Grifols SA
6.1.6 Kaneka Corporation
6.1.7 Fresenius Kabi
6.1.8 Haemonetics Corporation
6.1.9 Macopharma SA
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
For more information about this report visit https://www.researchandmarkets.com/r/y7ew38
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.